跳至主要内容
临床试验/NCT03072017
NCT03072017已完成不适用

Monitored Breathing Awareness Therapy for Insomnia Disorder in Older Adults: Phase 1 Open Label Pilot

University of Pennsylvania0 个研究点目标入组 20 人开始时间: 2016年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
主要终点
Sleep onset latency

研究概览

简要总结

Insomnia can be a chronic problem that leads to significant daytime fatigue, stress and numerous negative health consequences including depression. Advanced Medical Electronics, in partnership with researchers are the University of Pennsylvania, propose developing an innovative, non-drug, low-risk, intervention that can be implemented on mobile devices for the treatment of insomnia.

详细描述

Open-label pilot study in 20 older adults with insomnia (sleep onset latency>30 minutes for at least 3 nights a week) with a two week intervention period.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
65 Years 至 90 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Sleep onset latency > 30 min for at least 3 nights per week

排除标准

  • Unable to perform tests due to inability to communicate verbally/blindness, inability to write and read in English (the study questionnaires are in English and do not exist in validated form for other languages).
  • Cognitive impairment; cognitively impaired patients may not be able to comply with the protocol).
  • History of a diagnosed non-insomnia sleep disorder, such as sleep apnea or circadian rhythm disorder
  • Upper extremity motor impairment that would preclude MBAT therapy (e.g., quadriplegia).

结局指标

主要结局

Sleep onset latency

时间窗: two weeks

Time to fall asleep

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nalaka Gooneratne

Associate Professor

University of Pennsylvania

相似试验